Graf Akcie ACHC (Acadia Healthcare Company Inc). Diskuze k akciím ACHC. Aktuální informace ACHC.

Základní informace o společnosti Acadia Healthcare Company Inc (Akcie ACHC)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 5.07B
Hodnota podniku (EV) 7.03B
Tržby 2.508B
EBITDA 424.358M
Zisk -692.44
Růst v tržbách Q/Q -22.41 %
Růst v tržbách Y/Y -18.85 %
P/E (Cena vůči ziskům) N/A
Forward P/E 1.00
EV/Sales 2.80
EV/EBITDA 16.57
EV/EBIT N/A
PEG 0.72
Price/Sales 2.02
P/FCF 13.99
Price/Book 2.67
Účetní hodnota na akcii 21.31
Hotovost na akcii 4.25
FCF vůči ceně 7.15 %
Počet zaměstnanců 35,400
Tržba na zaměstnance 70.846k
Profit margin -32.16 %
Operating margin 14.62 %
Gross margin 33.03 %
EBIT margin -20.21 %
EBITDA margin 16.92 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst 31.48 %
EPS - Očekávaný růst příští rok 5.88 %
Return on assets -12.20 %
Return on equity -30.24 %
ROIC -7.12 %
ROCE -12.25 %
Dluhy/Equity 2.39
Čistý dluh/EBITDA 21.05
Current ratio 1.35
Quick Ratio 1.35
Volatilita 3.45
Beta 0.91
RSI 35.23
Cílová cena analytiků 41
Známka akcie (dle analytiků) 2.00
Insider ownership N/A %
Institutional ownership N/A %
Počet akcií 89.863M
Procento shortovaných akcií 4.25 %
Short ratio 6.08 %
Dividenda 0.00
Procentuální dividenda 0.00 %
Dividenda/Zisk 0.00 %
Obchodovaná od 2011
Země United States

Finanční výsledky akcie ACHC

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$3,107.462$3,012.442$2,836.316$2,810.914$1,794.492$1,004.601
Cost Of Goods Sold------
Gross Profit$3,107.462$3,012.442$2,836.316$2,810.914$1,794.492$1,004.601
Research And Development Expenses------
SG&A Expenses$2,081.224$2,006.087$1,846.822$1,844.765$1,170.858$676.316
Other Operating Income Or Expenses$-375.433$-354.498$-331.827$-312.556$-206.746$-110.654
Operating Expenses$2,702.93$2,599.699$2,398.434$2,365.772$1,473.682$831.838
Operating Income$404.532$412.743$437.882$445.142$320.81$172.763
Total Non-Operating Income/Expense$-268.544$-581.697$-201.084$-412.187$-156.057$-46.609
Pre-Tax Income$135.988$-168.954$236.798$32.955$164.753$126.154
Income Taxes$25.866$6.532$37.209$28.779$53.388$42.922
Income After Taxes$110.122$-175.486$199.589$4.176$111.365$83.232
Other Income------
Income From Continuous Operations$110.122$-175.486$199.589$4.176$111.365$83.232
Income From Discontinued Operations----$0.111$-0.192
Net Income$108.923$-175.75$199.835$6.143$112.554$83.04
EBITDA$580.563$582.031$590.747$590.569$391.069$208.628
EBIT$404.532$412.743$437.882$445.142$320.81$172.763
Basic Shares Outstanding888787866855
Shares Outstanding888787866855
Basic EPS$1.24$-2.01$2.30$0.07$1.65$1.51
EPS - Earnings Per Share$1.24$-2.01$2.30$0.07$1.64$1.50
# 2020 2019 2018 2017 2016 2015
Current Ratio1.16961.08181.24951.24811.01561.6521
Long-term Debt / Capital0.55350.57520.55470.60010.56610.5444
Debt/Equity Ratio1.25691.36871.25931.51671.33141.2255
Gross Margin100100100100100100
Operating Margin13.018113.701315.438415.836217.877517.1972
EBIT Margin13.018113.701315.438415.836217.877517.1972
EBITDA Margin18.682919.320920.82821.009921.792720.7673
Pre-Tax Profit Margin4.3762-5.60858.34881.17249.18112.5576
Net Profit Margin3.5052-5.83417.04560.21856.27228.266
Asset Turnover0.45170.4880.44150.46660.41940.4552
Inventory Turnover Ratio------
Receiveable Turnover9.14569.47059.552310.67468.28388.4864
Days Sales In Receivables39.909738.540838.210734.193344.061843.0101
ROE - Return On Equity4.3954-7.52097.75740.19266.61699.4478
Return On Tangible Equity-322.8705115.379-75.132-0.6998-22.0629147.7236
ROA - Return On Assets1.6008-2.8433.10670.06932.60253.7714
ROI - Return On Investment1.9627-3.19493.45430.0772.87144.3044
Book Value Per Share28.562426.683429.552925.00623.789714.8782
Operating Cash Flow Per Share-0.95290.15410.38510.68951.43140.7793
Free Cash Flow Per Share-0.0476-0.31330.8751.0645-0.5284-0.1538